This section is dedicated to more general regulatory affairs information, available for any regulatory affairs professional to consult, or for other stakeholder to get a first picture on what regulatory affairs are and how to approach the regulatory aspects of the commercialization of a pharma product in a new country.
So far, I included information on institutions that are relevant to regulatory affairs around the world and generalities on the submission dossier.
Regulatory Affairs in Latin America 